Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
Abstract New super-sensitive biomarker assay platforms for measuring Alzheimer’s disease (AD) core pathological markers in plasma have recently been developed and tested. Research findings from these technologies offer promising evidence for identifying the earliest stages of AD and correlating them...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2019-12-01
|
| Colecção: | Neurology and Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s40120-019-00167-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|